Eucamalduside A is primarily studied for its potential anti-inflammatory and neuroprotective properties. It has shown activity in modulating pathways associated with oxidative stress and neuronal damage, making it a compound of interest in the development of treatments for neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Research also indicates that it may inhibit certain pro-inflammatory cytokines, suggesting possible use in managing chronic inflammatory diseases. Due to its natural origin and structural complexity, it serves as a lead compound in the design of new bioactive molecules. Most studies remain in the preclinical phase, focusing on in vitro and animal models to evaluate efficacy and mechanism of action.